{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:30:31Z","timestamp":1790811031027,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejmg.2022.104594","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:07:08Z","timestamp":1660259228000},"page":"104594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS\/\u03b2thal genotype in an individual from the Democratic Republic of Congo"],"prefix":"10.1016","volume":"65","author":[{"given":"Robert","family":"Aquaron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalie","family":"Lasseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kelekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bonello-Palot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Badens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Arveiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Tshilolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2022.104594_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mehy.2011.01.029","article-title":"Bakare MO Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)- does hypermelanotic or hypomelanotic skin status of affected patients play a role?","volume":"76","year":"2011","journal-title":"Medical Hypothesis"},{"key":"10.1016\/j.ejmg.2022.104594_bib2","first-page":"311","article-title":"Battaglini PF Etudes seroanthropologiques des populations albinos et melanodermes Bamileke (Cameroun) : groupes erythrocytaires ABO et rhesus, hemoglobine S et sensibilit\u00e9 gustative \u00e0 la phenylthiocarbamide","volume":"44","author":"Aquaron","year":"1984","journal-title":"Med. Trop."},{"key":"10.1016\/j.ejmg.2022.104594_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10038-007-0181-y","article-title":"Grandchamp B Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene","volume":"52","author":"Aquaron","year":"2007","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib4","first-page":"5","article-title":"Brilliant M what can we learn from the distribution of the 2.7kb deletion mutation of the OCA2 gene in oculocutaneous albinism type 2(OCA2) in Cameroon and in Sub-Saharan countries?","volume":"1","author":"Aquaron","year":"2019","journal-title":"JSM Dermatol Clin Res"},{"key":"10.1016\/j.ejmg.2022.104594_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00439-005-1290-3","article-title":"The genetic legacy of western Bantu migrations","volume":"117","author":"Beleza","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1365-4362.1997.00259.x","article-title":"Pigmented skin lesions in tyrosinase-positive oculocutaneous albinos: a study in black South Africans","volume":"36","author":"Bothwell","year":"1997","journal-title":"Int. J. dermato."},{"key":"10.1016\/j.ejmg.2022.104594_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng0694-176","article-title":"African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism","volume":"7","author":"Durham-Pierre","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.survophthal.2009.11.004","article-title":"Sivaprabad S Sickle cell disease and the eye: old and new concepts","volume":"55","author":"Elagouz","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejmg.2022.104594_bib9","first-page":"68","article-title":"On giant dendritic freckles and melanocytes reactions in the skin of an albino patient","volume":"8","author":"Findlay","year":"1962","journal-title":"S. Afr. J. Lab. Clin. Med."},{"key":"10.1016\/j.ejmg.2022.104594_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.14988","article-title":"Patterns of skin cancer and treatment outcomes for patients with albinism at Kisangani Clinic, Democratic Republic of Congo","author":"Inena","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejmg.2022.104594_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.11604\/pamj.2020.35.127.21113","article-title":"Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo","volume":"35","author":"Kambale-Kombi","year":"2020","journal-title":"Pan African Med. J."},{"key":"10.1016\/j.ejmg.2022.104594_bib12","first-page":"1078","article-title":"The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in Southern African negroids","volume":"54","author":"Kedda","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1399-0004.1989.tb03365.x","article-title":"Albinism and skin cancer in southern Africa","volume":"36","author":"Kromberg","year":"1989","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib14","doi-asserted-by":"crossref","unstructured":"Lekalakala PT, Khammissa MAG, Kramer B, Ayo-Yusuf OA, Lemmer J, Feller L Oculocutaneous albinism and squamous cell carcinoma of the skin of the head and neck in sub-Saharan Africa. J. Skin Can. Vol 2015, Article ID 167847, 6 pages, https:\/\/doi.org\/10.1155\/2015\/167847-6.","DOI":"10.1155\/2015\/167847"},{"key":"10.1016\/j.ejmg.2022.104594_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","article-title":"Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding","volume":"50","author":"Martyn","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib16","first-page":"127","article-title":"Hartmann RC Albinism and sickle cell anemia in a negro family","volume":"9","author":"Massie","year":"1957","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1186\/s13256-021-03214-5","article-title":"Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report","volume":"15","author":"Mukinayi","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.ejmg.2022.104594_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1086\/497344","article-title":"Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa","volume":"77","author":"Pasmooij","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s004390050568","article-title":"Brilliant MH Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene","volume":"100","author":"Puri","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib20","first-page":"879","article-title":"The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12","volume":"51","author":"Ramsay","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejmg.2022.104594_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1096-8644(199910)110:2<143::AID-AJPA3>3.0.CO;2-J","article-title":"The peopling of Sub-Saharan Africa: the case study of Cameroon","volume":"110","author":"Spedini","year":"1999","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.ejmg.2022.104594_bib23","first-page":"586","article-title":"An intragenic deletion of the P gene is the most common mutation causing tyrosinase-positive oculocutaneous albinism in southern African negroids","volume":"56","author":"Stevens","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s004390050400","article-title":"Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation","volume":"99","author":"Stevens","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2022.104594_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jcp.2008.058958","article-title":"Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pionner project on 31 204 newborns","volume":"62","author":"Tshilolo","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ejmg.2022.104594_bib26","series-title":"Foetal Hemoglobin, Erythrocytes Containing Foetal Hemoglobin, and Hematological Features in Congolese Patients with Sickle Cell Anemia","first-page":"7","author":"Tshilolo","year":"2012"},{"key":"10.1016\/j.ejmg.2022.104594_bib27","author":"Ware"},{"key":"10.1016\/j.ejmg.2022.104594_bib28","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222001756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222001756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:46Z","timestamp":1761710026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721222001756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1769721222001756"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104594","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS\/\u03b2thal genotype in an individual from the Democratic Republic of Congo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104594"}}